Citations 1
ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma
Oluwole, Olalekan O. , Lazaryan, Aleksandr , Poddar, Soumya , Mao, Daqin , Peng, Andrew C., Kilcoyne, Adrian , Nahas, Myrna , Neelapu, Sattva S. , Oluwole, Olalekan O , Kenderian, Saad S. , Shiraz, Parveen , Karmali, Reem , Reshef, Ran , McCarthy, Philip L. , Ghosh, Nilanjan , Filosto, Simone , Peng, Andrew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10318-10320
